Cboe Global Markets, Inc. (NASDAQ:CBOE - Get Free Report) has been given an average recommendation of "Reduce" by the twelve analysts that are presently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $219.64.
A number of research firms have recently commented on CBOE. Morgan Stanley cut shares of Cboe Global Markets from an "overweight" rating to an "underweight" rating and reduced their target price for the stock from $256.00 to $215.00 in a research report on Wednesday, May 14th. Loop Capital set a $227.00 target price on shares of Cboe Global Markets in a research report on Monday, May 5th. Piper Sandler boosted their target price on shares of Cboe Global Markets from $234.00 to $245.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. Oppenheimer boosted their target price on shares of Cboe Global Markets from $237.00 to $249.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. Finally, Barclays boosted their target price on shares of Cboe Global Markets from $232.00 to $245.00 and gave the stock an "equal weight" rating in a research report on Friday, May 2nd.
Read Our Latest Stock Report on Cboe Global Markets
Cboe Global Markets Trading Down 0.3%
Shares of CBOE stock opened at $231.35 on Thursday. The stock has a market cap of $24.23 billion, a price-to-earnings ratio of 32.04, a price-to-earnings-growth ratio of 1.75 and a beta of 0.43. The company has a quick ratio of 1.39, a current ratio of 1.78 and a debt-to-equity ratio of 0.34. Cboe Global Markets has a fifty-two week low of $166.88 and a fifty-two week high of $236.02. The firm's 50 day moving average price is $225.58 and its two-hundred day moving average price is $213.33.
Cboe Global Markets (NASDAQ:CBOE - Get Free Report) last posted its earnings results on Friday, May 2nd. The company reported $2.50 EPS for the quarter, topping analysts' consensus estimates of $2.36 by $0.14. Cboe Global Markets had a net margin of 18.64% and a return on equity of 22.02%. During the same quarter in the previous year, the company earned $2.15 EPS. The company's quarterly revenue was up 12.6% on a year-over-year basis. On average, analysts anticipate that Cboe Global Markets will post 8.96 EPS for the current year.
Cboe Global Markets Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 30th were paid a dividend of $0.63 per share. The ex-dividend date of this dividend was Friday, May 30th. This represents a $2.52 annualized dividend and a yield of 1.09%. Cboe Global Markets's payout ratio is 33.03%.
Insiders Place Their Bets
In other Cboe Global Markets news, EVP Catherine R. Clay sold 3,598 shares of the business's stock in a transaction on Friday, May 23rd. The shares were sold at an average price of $226.58, for a total transaction of $815,234.84. Following the completion of the sale, the executive vice president owned 2,183 shares in the company, valued at $494,624.14. The trade was a 62.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.22% of the stock is currently owned by insiders.
Institutional Trading of Cboe Global Markets
Institutional investors have recently added to or reduced their stakes in the business. Alliancebernstein L.P. grew its position in shares of Cboe Global Markets by 208.4% during the fourth quarter. Alliancebernstein L.P. now owns 7,685,489 shares of the company's stock worth $1,501,745,000 after acquiring an additional 5,193,339 shares during the last quarter. Norges Bank bought a new position in shares of Cboe Global Markets during the fourth quarter worth about $269,524,000. GAMMA Investing LLC grew its position in shares of Cboe Global Markets by 29,094.5% during the first quarter. GAMMA Investing LLC now owns 1,216,535 shares of the company's stock worth $275,290,000 after acquiring an additional 1,212,368 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Cboe Global Markets by 400.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,067,566 shares of the company's stock worth $241,580,000 after acquiring an additional 854,325 shares during the last quarter. Finally, Nuveen LLC bought a new position in shares of Cboe Global Markets during the first quarter worth about $74,789,000. Institutional investors own 82.67% of the company's stock.
About Cboe Global Markets
(
Get Free ReportCboe Global Markets, Inc is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading. Cboe offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, U.S. and European equities, exchange-traded products (ETPs), global foreign exchange (FX) and multi-asset volatility products based on the VIX Index.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cboe Global Markets, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cboe Global Markets wasn't on the list.
While Cboe Global Markets currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.